Product Benefits

• Intermediate-Acting/Basal Coverage: Provides a sustained release of insulin to cover the body's basal (background) insulin needs for up to approximately 24 hours, helping to control blood sugar between meals and overnight.

• Broad Indication for Diabetes: Effective in the treatment of all patients with Type 1 Diabetes, many patients with Type 2 Diabetes (especially when oral agents and/or diet are inadequate), and in the management of Gestational Diabetes.

• Flexible Basal Insulin Regimen: Can be used alone or combined with short-acting (regular) insulin for a more intensive therapy regimen (basal-bolus approach).

• Stabilization During Stress/Illness: Indicated for the initial stabilization of diabetes during periods of acute stress, such as severe infections or major surgery, and for conditions like diabetic ketoacidosis and hyperosmolar non-ketotic syndrome.

• Physiologically Identical: Contains Isophane Human Insulin, which is produced using recombinant DNA technology and has the same structure as the insulin produced by the human body.¹

• Contributes to Long-Term Control: Optimized glycemic control with insulin therapy can effectively delay the onset and slow the progression of long-term diabetic complications.